CorticoMetrics seeks to improve the state of clinical decision making in neuroradiology, augmenting qualitative assessment with quantitative analysis of magnetic resonance imaging (MRI) scans of the brain. CorticoMetrics is targeting a number of neurological disorders and conditions that affect millions of people worldwide, including epilepsy, dementia, multiple sclerosis, traumatic brain injury, and hydrocephalus. The foundation of CorticoMetrics' software technology is FreeSurfer, a high-quality suite of automated neuroimaging tools for brain morphometry, developed at Massachusetts General Hospital (MGH) for research purposes. CorticoMetrics is working to bring these tools to clinical practice. CorticoMetrics is a privately-held company composed of a team with extensive scientific, engineering, management and business experience in neuroimaging and computing technology industries. Launched in 2012 to spin-off technology developed at the Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, CorticoMetrics continues to work with MGH in research and product development through several NIH SBIR/STTR grant-funded projects.